Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2)

Internal Medicine

Volumn 44, Issue 3, 2005, Pages 188-195

  Yazaki, Masahide ^b   Takei, Yo Ichi ^b   Kobayashi, Keiko ^a   Saheki, Takeyori ^a   Ikeda, Shu Ichi ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain edema; Citrin; Cytosolic NADH; Glycerol; Mannitol; Type II citrullinemia

Indexed keywords

AMMONIA; APROTININ; ARGININE; CHLORPROMAZINE; CITRULLINE; GLYCEROL; HALOPERIDOL; KANAMYCIN; LACTULOSE; LORAZEPAM; MANNITOL; NITRAZEPAM; PHENYTOIN;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN EDEMA; CITRULLINEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TONIC SEIZURE;

ADULT; AGE OF ONSET; BRAIN EDEMA; CALCIUM-BINDING PROTEINS; CITRULLINEMIA; DISEASE PROGRESSION; DIURETICS, OSMOTIC; DNA; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GLYCEROL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MANNITOL; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; ORGANIC ANION TRANSPORTERS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17744379398     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.188     Document Type: Article

References (32)

1. Brusilow SW, Horwich AL. Urea cycle enzymes. in: The Metabolic and Molecular Bases of Inherited Disease, 7 th ed. Scriver CR, Beaudet AL., Sly WS, Valle D, Eds. McGraw-Hill, New York, 1995: 1187-1232.
2. Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: biochemical and molecular approach. Rev Physiol Biochem Pharmacol 108: 21-68, 1987.
3. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22: 159-163, 1999.
4. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47: 333-341, 2002.
5. Ikeda S, Yazaki M, Takei Y, et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 71: 663-670, 2001.
6. Ikeda S, Takei Y, Hashikura Y. Liver transplantation as treatment for neurological disorders. Expert Rev Neurotherapeutics 3 547-555, 2003.
7. Yazaki M, Ikeda S, Takei Y, et al. Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation. Transplantation 62: 1679-1684, 1996.
8. Yazaki M, Hashikura Y, Takei Y, et al. Feasibility of auxiliary partial orthotopic liver transplanation from living donors for patients with adult-onset type II citrullinemia. Liver Transplant 10 550-554, 2004.
9. Oshiro S, Kochinda T, Tana T, et al. A patient with adult-onset type II citrullinemia on a long-term hemodialysis: reversal of clinical symptoms and brain MRI findings. Am J Kidney Dis 39: 189-192, 2002.
10. Takashima Y, Koide M, Fukunaga H, et al. Recovery from marked altered consciousness in a patient with adult-onset type II citrullinemia diagnosed by DNA analysis and treated with a living related partial liver transplantation. Intern Med 41: 555-560, 2002.
11. 3 level of adult type citrullinemia. Rinsho Byori 34: 1213-1218, 1986 (in Japanese).
12. Yamamoto S, Hino K, Ohumi T, et al. An autopsy case of adult-type citrullinemia accompanied with cerebral bleeding. Naika 58 881-883, 1986 (in Japanese).
13. Ikeda M, Orimo S, Kurosawa T, Arai M, Hiyamuta E. A case of citrullinemia with cluster type distribution of argininosuccinate synthetase in the liver. Rinsho Shinkeigaku (Clin Neurol) 27: 931-935, 1987 (in Japanese, Abstract in English).
14. Shindo K, Tsunoda S, Shiozawa Z. Adverse effects of branched chain amino acid transfusion on type II citrullinemia. Rinsho Shinkeigaku (Clin Neurol) 31: 407-411, 1991 (in Japanese, Abstract in English).
15. Yuki N, Kaneko K, Yanagisawa K, Ohno T, Miyatake T. The correlation of consciousness level and the concentration of CSF ammonia in a patient with adult-type citrullinemia. Rinsho Shinkeigaku (Clin Neurol) 31: 765-767, 1991 (in Japanese, Abstract in English).
16. Ishii A, Ohkoshi N, Oka Y, Ban S, Takahashi A. A case of citrullinemia associated with isolated ACTH deficiency, rapidly developing coma. Rinsho Shinkeigaku (Clin Neurol) 32: 853-858, 1992 (in Japanese, Abstract in English).
17. 3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia. Intern Med 39: 925-929, 2000.
18. Hoshi N, Mukai S, Shinzawa J, et al. A case of adult-onset type II citrullinemia in which oral administration of L-arginine granules improved the patient's encephalopathy and the increased level of ammonia. Kanzo 43: 492-497, 2002 (in Japanese).
19. Imamura Y, Kobayashi K, Shibatou T, et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26: 68-72, 2003.
20. Kobayashi K, Horiuchi M, Saheki T. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160-1165, 1997.
21. Hagiwara N, Sekijima Y, Takei Y, et al. Hepatocellular carcinoma in a case of adult-onset type II citrullinemia. Intern Med 42: 978-982, 2003.
22. Yasuda T, Yamaguchi N, Kobayashi K, et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107 537-545, 2000.
23. Yamaguchi N, Kobayashi K, Yasuda T, et al. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19: 122-130, 2002.
24. Saheki T, Kobayashi K, Iijima M, et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. Mol Genet Matab 81: S20-S26, 2004.
25. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060-5069, 2001.
26. Takagi H, Saitoh T, Kitahara T, Morii S, Ohwada T, Yada K. The mechanism of ICP reducing effect of mannitol. in: Intracranial Pressure, Ishii S, Nagai H, Brock M, Eds. Springer-Verlag, Heidelberg, 1993: 729-737.
27. Williamson DH, Veloso D, Ellington EV, Krebs HA. Changes in the concentrations of hepatic metabolites on administration of dihydroxyacetone or glycerol to starved rats and their relationship to the control of ketogenesis. Biochem J 114: 575-584, 1969.
28. Sinasac DS, Moriyama M, Jalil MA, et al. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia. Mol Cell Biol 24: 527-536, 2004.
29. Moriyama M. Investigation of the metabolic characterization using citrin-knockout mice. The effect of pyruvate. Presented at the Second annual meeting of adult-onset type II citrullinemia, Tokyo, March 20, 2004, p 11 (Abstract in Japanese).
30. Arakawa M, Kondo T, Mitsui H, Suzuki S, Shiba M. Glycerol induced haemolysis of mammalian erythrocytes and inhibition of the lysis by fructose. Nippon Yakurigaku Zasshi 73: 541-547, 1977 (in Japanese).
31. Gotoh F, Tazaki Y, Fukuuchi Y, et al. Intravenous administration of hypertonic glycerol solution in neurologic diseases: II. Clinical evaluation of 10% (W/V) glycerol, 5% (W/V) fructose saline solution (CGA30). Jpn J Clin Exp Med 55: 2327-2335, 1978.
32. Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol 34: 548-554, 2001.